{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:09:01Z","timestamp":1762430941325},"reference-count":28,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ijpharm.2014.10.032","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T21:31:19Z","timestamp":1413495079000},"page":"167-175","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["In vivo SPECT imaging of [123I]-labeled pentamidine pro-drugs for the treatment of human African trypanosomiasis, pharmacokinetics, and bioavailability studies in rats"],"prefix":"10.1016","volume":"477","author":[{"given":"Bj\u00f6rn","family":"Cohrs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"L\u00fctzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juraj","family":"Culman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Clement","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maaz","family":"Zuhayra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2014.10.032_bib0005","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pt.2012.12.005","article-title":"Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story","volume":"29","author":"Baker","year":"2013","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0010","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2217\/fmb.11.88","article-title":"Drug resistance in human African trypanosomiasis","volume":"6","author":"Barrett","year":"2011","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0015","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1128\/AAC.36.9.1825","article-title":"Primary and secondary metabolism of pentamidine by rats","volume":"36","author":"Berger","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0020","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0883-2889(92)90193-I","article-title":"Preparation and stability of a radioiodinated pentamidine isethionate analog","volume":"43","author":"Blower","year":"1992","journal-title":"Int. J. Radiat. Appl. Instrum. A"},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0773.1995.tb00999.x","article-title":"Metabolism is an important route of pentamidine elimination in the rat: disposition of 14C-pentamidine and identification of metabolites in urine using liquid chromatography\u2013tandem mass spectrometry","volume":"77","author":"Bronner","year":"1995","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0030","series-title":"Klinische Nuklearmedizin","author":"B\u00fcll","year":"1987"},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0035","series-title":"Pharmakokinetik Des Pentoximesters, Dissertation (PhD thesis)","author":"B\u00fcrenheide","year":"2006"},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0040","first-page":"653","article-title":"Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging","volume":"5","author":"Chrastina","year":"2010","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0045","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1081\/DMR-120005643","article-title":"Reduction of N-hydroxylated compounds: amidoximes (N-hydroxyamidines) as pro-drugs of amidines","volume":"34","author":"Clement","year":"2002","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0050","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/cmdc.200600079","article-title":"Diacetyldiamidoximeester of pentamidine, a prodrug for treatment of protozoal diseases: synthesis, in vitro and in vivo biotransformation","volume":"1","author":"Clement","year":"2006","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ardp.19923250114","article-title":"Reduction of amidoxime derivatives to pentamidine in vivo","volume":"325","author":"Clement","year":"1992","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0060","first-page":"1009","article-title":"Amidoximes of pentamidine: synthesis: trypanocidal and leishmanicidal activity","volume":"35","author":"Clement","year":"1985","journal-title":"Arzneimmittelforschung"},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0065","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/infdis\/156.6.885","article-title":"Pentamidine pharmacokinetics in patients with AIDS with impaired renal function","volume":"156","author":"Conte","year":"1987","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0070","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00018-002-8472-0","article-title":"Sleeping sickness and the brain","volume":"59","author":"Enanga","year":"2002","journal-title":"Cell. Mol. Life Sci. (CMLS)"},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/infdis\/160.3.507","article-title":"Comparison of tissular disposition of pentamidine mesylate in the rat after aerosol or parenteral administration","volume":"160","author":"Farinotti","year":"1989","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0080","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0020-708X(75)90036-8","article-title":"Studies with radioactive iodine labelled oestrogens as prostate scanning agents","volume":"26","author":"Ghanadian","year":"1975","journal-title":"Int. J. Appl. Radiat. Isot."},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0085","doi-asserted-by":"crossref","first-page":"8173","DOI":"10.1021\/jm8010417","article-title":"The fourth molybdenum containing enzyme mARC: cloning and involvement in the activation of N-hydroxylated prodrugs","volume":"51","author":"Gruenewald","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0090","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00259-005-1807-y","article-title":"Validation of brain tumour imaging with p-[123I]iodo-L-phenylalanine and SPECT","volume":"32","author":"Hellwig","year":"2005","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0095","series-title":"Neue Prodrugs von Diamidinen zur Therapie Protozoischer Erkrankungen (PhD thesis)","author":"Hungeling","year":"2009"},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0100","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1002\/cmdc.201100422","article-title":"New prodrugs of the antiprotozoal drug pentamidine","volume":"6","author":"Kotthaus","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0105","series-title":"In Vivo und in Vitro Biotransformation von Pentamidinderivaten (Dissertation)","author":"Rieckert","year":"1999"},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0110","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1124\/jpet.108.149872","article-title":"Pentamidine movement across the murine blood\u2013brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein","volume":"329","author":"Sanderson","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0115","series-title":"The Antimicrobial Drugs","author":"Scholar","year":"2000"},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0120","series-title":"Transport- und Biotransformationsstudien mit Amidinprodrugs (PhD thesis)","author":"Schwering","year":"2010"},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0125","doi-asserted-by":"crossref","first-page":"e1007","DOI":"10.1371\/journal.pntd.0001007","article-title":"The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000\u20132009: the way forward","volume":"5","author":"Simarro","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0130","first-page":"245","article-title":"Pharmacokinetics and toxicokinetics of pentamidine in the rat following intravenous and aerosol administration","volume":"85","author":"Terlinden","year":"1983","journal-title":"Med. Klin. Munich Ger."},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0135","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0969-8051(97)00006-1","article-title":"Disposition of intravenous 123iodopentamidine in man","volume":"24","author":"Thomas","year":"1997","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ijpharm.2014.10.032_bib0140","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/cpt1970114505","article-title":"Pentamidine: clinical pharmacologic correlations in man and mice","volume":"11","author":"Waalkes","year":"1970","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517314007558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517314007558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T12:58:14Z","timestamp":1538139494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517314007558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":28,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0378517314007558"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2014.10.032","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo SPECT imaging of [123I]-labeled pentamidine pro-drugs for the treatment of human African trypanosomiasis, pharmacokinetics, and bioavailability studies in rats","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2014.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}